Flumazenil → Flumazenil Impurity 8

HRID 67540

반응식

HRID 67540 반응식
[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH2:18]C)=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1.[C-]#N.[K+]>CO>[F:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[CH:12]=[N:13][C:14]([C:15]([O:17][CH3:18])=[O:16])=[C:10]3[CH2:9][N:8]([CH3:20])[C:7](=[O:21])[C:6]=2[CH:22]=1

참가 물질

4

반응물 2

HCID 3373FlumazenilHCID 9032Potassium Cyanide

생성물 1

HCID 20515347Flumazenil Impurity 8

시약·촉매·용매 1

HCID 887Methanol용매

실험 절차

A mixture of 3.5 g (11.5 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, 0.15 g of potassium cyanide and 40 ml of methanol is stirred at the boiling point for 2.5 hours. The solvent is distilled off on a rotary evaporator and the residue is taken up in chloroform. After filtration from insoluble material, the filtrate is concentrated. After recrystallisation of the residue from ethyl acetate, there is obtained methyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 195°-196.5° C.

후처리

  1. distillationThe solvent is distilled off on a rotary evaporator
  2. filtrationAfter filtration from insoluble material
  3. concentrationthe filtrate is concentrated
  4. customAfter recrystallisation of the residue from ethyl acetate

출처 및 근거

ORD 기록
ord-8b76b509752b454bb121227e7f732e0f
출처 데이터셋
uspto-grants-1982_08
특허 번호
US04346035

연결된 노트

불러오는 중…